Latest Health News
U.S. Finalizes Withdrawal from WHO, Impacting Global Outbreak Response
The U.S. completed its withdrawal from the World Health Organization on January 22, 2026, ending a 78-year commitment and owing over $130 million. Experts warn it hampers vaccine development, data sharing, and could cause 750,000 excess deaths, mostly in children. Critics highlight risks to U.S. early warnings on pandemics from countries like China.
One Year of Global Health Chaos from U.S. Aid Freeze
Marking 365 days since the foreign aid freeze, reports reflect disruptions in HIV funding, research networks, and trust, urging sustainable domestic financing. Outlets like Bhekisisa, Health Policy Watch, Science, Nature, and The Lancet detail human and scientific costs.
Future challenges demand more than restoring old funding streams.
U.S. Congress Maintains FY26 Global Health Funding
Bipartisan FY26 bills reject $2B HIV cuts, sustaining funds for HIV, TB, malaria, polio, family planning, and UN agencies like UNAIDS. CDC global health at $693M and NIH Fogarty at $95M match FY25 levels.
Advocacy calls for swift approval and accountability.
MD Anderson Unveils Cancer Vaccine for Lynch Syndrome Prevention
A Phase Ib/II trial shows NOUS-209 vaccine offers early prevention for high-risk Lynch syndrome patients via immune approaches. Led by Eduardo Vilar-Sanchez, it intercepts cancer pre-development.
This advances preventive care strategies.
Novel Immunotherapy Overcomes Cancer Treatment Resistance
Phase I trial of linavonkibart (SRK-181) targets TGF-beta1, aiding resistance to anti-PD-1 therapies in multiple cancers. Led by Timothy Yap at MD Anderson, it shows promising early potential.
Previously failed attempts make this a significant step.
Engineered Nanobodies Boost Respiratory Defenses Against Viruses
Preclinical study demonstrates bispecific nanobodies enhance mucosal protection against influenza and reduce SARS-CoV-2 transmission. Multi-institutional research published in Nature Nanotechnology.
Improves defenses in the respiratory tract.
Mount Sinai's CAR T Therapy Targets Tumor Macrophages in Cancers
Experimental CAR T cells eliminate tumor-suppressing macrophages, produce IL-12, and cure metastatic lung/ovarian cancers in mice. Reshapes tumor microenvironment antigen-independently for broader use.
Human trials needed; proof-of-concept for refractory cancers.
Five Major Global Health Shifts Predicted for 2026
World Health Summit CEO outlines UN80 governance restructuring, pandemic preparedness, power dynamics, public-private models, and scientific integrity pressures. Shapes challenges and opportunities ahead.
Published in Economist Impact editorial.
AI and Genomics Drive Six Healthcare Trends in 2026
Advancements in AI for diagnosis, remote monitoring, imaging; life sciences like CRISPR, mRNA vaccines, bioprinting expand. 75% health tech funding AI-focused; federal pushes acceleration.
Consumer chatbots and robotic surgery grow.
iECURE's ECUR-506 Gains FDA RMAT and UK Passport for Genomic Therapy
ECUR-506 secures U.S. FDA Regenerative Medicine Advanced Therapy designation and UK Innovation Passport for genomic medicine. Positions it for experimental clinical practice advances.
Removes brakes on genomic applications.
WHO Benefits U.S. in Disease Surveillance and Polio Eradication
WHO's network aided Marburg containment in Rwanda and polio reduction (99.9% since 1988) in hard-to-reach areas. U.S. engagement advances American health security.
Withdrawal risks these gains.
Hepatitis B Vaccine Trial Insights from Guinea-Bissau
New reporting highlights ongoing hepatitis B vaccine trial in Guinea-Bissau amid global health reflections. Part of broader disruptions and future planning discussions.
Underscores research network fractures.